推薦此記錄: Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant -Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic syndrome